Literature DB >> 33352713

Fourier-Transform Infrared Spectroscopy of Skeletal Muscle Tissue: Expanding Biomarkers in Primary Mitochondrial Myopathies.

Jacopo Gervasoni1, Aniello Primiano1,2, Federico Marini3, Andrea Sabino2, Alessandra Biancolillo4, Riccardo Calvani1,5, Anna Picca1,5, Emanuele Marzetti1,2, Silvia Persichilli1,2, Andrea Urbani1,2, Serenella Servidei1,2, Guido Primiano1,2.   

Abstract

Primary mitochondrial myopathies (PMM) are a group of mitochondrial disorders characterized by a predominant skeletal muscle involvement. The aim of this study was to evaluate whether the biochemical profile determined by Fourier-transform infrared (FTIR) spectroscopic technique would allow to distinguish among patients affected by progressive external ophthalmoplegia (PEO), the most common PMM presentation, oculopharyngeal muscular dystrophy (OPMD), and healthy controls. Thirty-four participants were enrolled in the study. FTIR spectroscopy was found to be a sensitive and specific diagnostic marker for PEO. In particular, FTIR spectroscopy was able to distinguish PEO patients from those affected by OPMD, even in the presence of histological findings similar to mitochondrial myopathy. At the same time, FTIR spectroscopy differentiated single mtDNA deletion and mutations in POLG, the most common nuclear gene associated with mitochondrial diseases, with high sensitivity and specificity. In conclusion, our data suggest that FTIR spectroscopy is a valuable biodiagnostic tool for the differential diagnosis of PEO with a high ability to also distinguish between single mtDNA deletion and mutations in POLG gene based on specific metabolic transitions.

Entities:  

Keywords:  FTIR; biomarkers; differential diagnosis; metabolomics; mitochondrial diseases; mtDNA; oculopharyngeal muscular dystrophy (OPMD); personalized medicine; progressive external ophthalmoplegia (PEO)

Year:  2020        PMID: 33352713      PMCID: PMC7766922          DOI: 10.3390/genes11121522

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  17 in total

1.  Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies.

Authors:  Ewa Szymańska; Edoardo Saccenti; Age K Smilde; Johan A Westerhuis
Journal:  Metabolomics       Date:  2011-07-08       Impact factor: 4.290

2.  An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region.

Authors:  M Zeviani; S Servidei; C Gellera; E Bertini; S DiMauro; S DiDonato
Journal:  Nature       Date:  1989-05-25       Impact factor: 49.962

Review 3.  Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Amel Karaa; Mary Kay Koenig; Irina Anselm; Catherine Brunel-Guitton; John Christodoulou; Bruce H Cohen; David Dimmock; Gregory M Enns; Marni J Falk; Annette Feigenbaum; Richard E Frye; Jaya Ganesh; David Griesemer; Richard Haas; Rita Horvath; Mark Korson; Michael C Kruer; Michelangelo Mancuso; Shana McCormack; Marie Josee Raboisson; Tyler Reimschisel; Ramona Salvarinova; Russell P Saneto; Fernando Scaglia; John Shoffner; Peter W Stacpoole; Carolyn M Sue; Mark Tarnopolsky; Clara Van Karnebeek; Lynne A Wolfe; Zarazuela Zolkipli Cunningham; Shamima Rahman; Patrick F Chinnery
Journal:  Genet Med       Date:  2017-07-27       Impact factor: 8.822

Review 4.  Mitochondrial diseases.

Authors:  Gráinne S Gorman; Patrick F Chinnery; Salvatore DiMauro; Michio Hirano; Yasutoshi Koga; Robert McFarland; Anu Suomalainen; David R Thorburn; Massimo Zeviani; Douglass M Turnbull
Journal:  Nat Rev Dis Primers       Date:  2016-10-20       Impact factor: 52.329

5.  A severe linezolid-induced rhabdomyolysis and lactic acidosis in Leigh syndrome.

Authors:  Guido Primiano; Serenella Servidei
Journal:  J Inherit Metab Dis       Date:  2020-11-18       Impact factor: 4.982

Review 6.  Mitochondrial Diseases: A Diagnostic Revolution.

Authors:  Katherine R Schon; Thiloka Ratnaike; Jelle van den Ameele; Rita Horvath; Patrick F Chinnery
Journal:  Trends Genet       Date:  2020-07-13       Impact factor: 11.639

7.  FT-IR analysis of urinary stones: a helpful tool for clinician comparison with the chemical spot test.

Authors:  Aniello Primiano; Silvia Persichilli; Giovanni Gambaro; Pietro Manuel Ferraro; Alessandro D'Addessi; Andrea Cocci; Arcangelo Schiattarella; Cecilia Zuppi; Jacopo Gervasoni
Journal:  Dis Markers       Date:  2014-04-27       Impact factor: 3.434

8.  Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.

Authors:  Gráinne S Gorman; Andrew M Schaefer; Yi Ng; Nicholas Gomez; Emma L Blakely; Charlotte L Alston; Catherine Feeney; Rita Horvath; Patrick Yu-Wai-Man; Patrick F Chinnery; Robert W Taylor; Douglass M Turnbull; Robert McFarland
Journal:  Ann Neurol       Date:  2015-03-28       Impact factor: 10.422

9.  International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16-18 November 2016, Rome, Italy.

Authors:  Michelangelo Mancuso; Robert McFarland; Thomas Klopstock; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2017-09-08       Impact factor: 4.296

10.  Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensus.

Authors:  Maaike C De Vries; David A Brown; Mitchell E Allen; Laurence Bindoff; Gráinne S Gorman; Amel Karaa; Nandaki Keshavan; Costanza Lamperti; Robert McFarland; Yi Shiau Ng; Mar O'Callaghan; Robert D S Pitceathly; Shamima Rahman; Frans G M Russel; Kristin N Varhaug; Tom J J Schirris; Michelangelo Mancuso
Journal:  J Inherit Metab Dis       Date:  2020-02-07       Impact factor: 4.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.